(Total Views: 158)
Posted On: 06/02/2024 8:13:09 PM
Post# of 48

News - May 29. RespireRx Pharmaceuticals Inc. Announces a Department of Defense Award to Fund a Phase 2 Clinical Study to Determine the Safety and Efficacy of CX1739, its Lead AMPAkine, to Improve Bladder Function in Patients with Spinal Cord Injury
https://www.otcmarkets.com/stock/RSPI/news/st...id=2874640
https://www.otcmarkets.com/stock/RSPI/news/st...id=2874640


"Per Ardua Ad Astra" - "Through Adversity To The Stars"
A very apposite motto for those who trade successfully in the OTC market..
All posts are my opinion - trade at your own risk.
A very apposite motto for those who trade successfully in the OTC market..
All posts are my opinion - trade at your own risk.